Abstract: A cocrystalline DHEA composition with at least one additional coformer is disclosed for therapeutic formulations. The cocrystalline DHEA/coformer formulation including at least one coformer chosen from the group consisting of glutaric acid, maleic acid, tartaric acid, fructose, and wherein the L-isomer of tartaric acid and the D-isomer of fructose are utilized. The cocrystalline DHEA/coformer formulations include certain excipients as a solubilizer or inhibitor.

Abstract: A cocrystalline DHEA composition with at least one additional coformer is disclosed for therapeutic formulations. The cocrystalline DHEA/coformer formulation including at least one coformer chosen from the group consisting of glutaric acid, maleic acid, tartaric acid, fructose, and wherein the L-isomer of tartaric acid and the D-isomer of fructose are utilized. The cocrystalline DHEA/coformer formulations include certain excipients as a solubilizer or inhibitor.

Abstract: Excavator that comprises a drive unit, an excavator tool and a mounting device for the excavator tool and wherein the mounting device comprises at least two arms that are arranged to be connected to the excavator tool. The excavator comprises resilient portions located in at least two different locations in which the resilient portions are arranged to allow the excavator tool to move in at least one plane relative to the drive unit when the excavator tool is mounted on the mounting device and thereby allow the excavator tool to oscillate in the at least one plane.

Abstract: An apparatus measures the tread of a tyre on a vehicle, in which a laser line generator (34) generates an elongate pattern of light. Mirrors (36) are arranged to reflect light from the laser line generator (34) onto the rolling surface of the tyre. Mirrors (36, 38, 42) are arranged to reflect light from different regions of the rolling surface of the tyre towards a camera (32). The camera images the regions of the rolling surface of the tyre. The apparatus may be hand-held or arranged such that a tyre to be aged is driven onto or over it.

Abstract: Excavator (10) that comprises a drive unit (11), an excavator tool (12) and a mounting device (14) for the excavator tool (12), which mounting device (14) comprises at least two arms (30) that are arranged to be connected to the excavator tool (12). The excavator (10) comprises resilient means (38) that are located in at least two different locations (A, B), which resilient means (38) are arranged to allow the excavator tool (12) to move in at least one plane (20) relative to the drive unit (11) when said excavator tool (12) is mounted on the mounting device (14) and thereby allow the excavator tool (12) to oscillate in said at least one plane.

Abstract: The described messaging arrangement for delivering communication messages to recipients in a communication system comprises a number of messaging servers (201-204), a common message store (205) and a dispatcher (206). The messaging servers (201-204) are able to receive a message destined to a recipient, to store the message in the common message store and to inform the dispatcher of the received message that has been stored in the common message store. The dispatcher is then arranged to decide which messaging server to invoke for delivery of the message to the recipient. This decision could be made based on delivery preferences of the recipient. Thereafter, the dispatcher invokes the messaging server that has been decided to deliver the message, and the decided messaging server retrieves and delivers the message to the recipient. If necessary, the decided messaging server adapts the message to a message type handled by the decided messaging server.

Abstract: Method for delivering electronic messages to a user including: receiving an electronic message from a sending party, said message containing a destination identity associated with said user, retrieving an IP address currently assigned to a terminal used by said user, based on said destination identity associated with said user, and delivering the electronic message to said terminal with the retrieved IP address as the destination address. A corresponding arrangement is also described.

Abstract: This invention relates to a novel estrogen receptor-related nuclear receptor, hereinafter termed “ER?” having the amino acid sequence of FIG. 1, 13A or 14A or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1, 13A or 13B or an amino acid sequence functionally similar to that sequence. The invention also relates to DNA sequences encoding the receptor. The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and other hormonal effects.

Abstract: A textile mat, which is adapted to form a thermal comfort layer for a piece of seating or lying furniture and made of a moisture-permeable and a moisture-absorbing fibre layer, is made of biodegradable fibres only. Binder fibres are embedded in the moisture-absorbing fibre layer to keep it together and form an adhesive surface for keeping the two fibre layers together. A cushion is made of a textile body with a thermal and a biochemical comfort layer. The body is made in one piece of biodegradable fibres, the thermal comfort layer being formed of said textile mat and the biomechanical comfort layer being formed of a vertically pleated, set wadding. Biodegradable binder fibres are embedded in the wadding. In a method of making a cushion with a thermal and biomechanical comfort layer, a vertically pleated, set wadding is cut to a predetermined size.

Abstract: This invention relates to the field of estrogen receptors and particularly though not exclusively on the effect of estrogen receptors and ligands for estrogen receptors on the prevention or treatment of obesity. The invention also relates to the effect of estrogen receptors and their ligands on lipoprotein levels in mammals.

Abstract: This invention relates to the field of estrogen receptors and particularly though not exclusively on the effect of estrogen receptors and ligands for estrogen receptors on the prevention or treatment of obesity. The invention also relates to the effect of estrogen receptors and their ligands on lipoprotein levels in mammals.

Abstract: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.

Abstract: Targeted messaging, for example advertisements, may be provided to an end user terminal connectable to a service node in a communications network, said network comprising a library node connected to the service node and comprising messages, such as advertisements, in different formats adapted to different access types, by the following steps: requesting the delivery of at least one message from the library node to the service node for distribution to the terminal, while specifying in the request the access type used by the terminal, and providing from the library node to the service node the appropriate version of the at least one message in dependence of the access type used by the terminal. One or more parameter, such as demographic data, may be specified for how to select a message from the library node.

Abstract: This invention relates to methods of cancer treatment and prognosis and in particular to such methods involving the HES-1 protein.

Abstract: This invention relates to a novel estrogen receptor-related nuclear receptor, hereinafter termed “ER&bgr;” having the amino acid sequence of FIGS. 1, 13A or 14A or substantially the same amino acid sequence as the amino acid sequence shown in FIGS. 1, 13A or 13B or an amino acid sequence functionally similar to that sequence. The invention also relates to DNA sequences encoding the receptor. The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and other hormonal effects.

Abstract: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.

Abstract: This invention relates to a new nuclear receptor coactivator RAP250 and to its uses.

Abstract: This invention relates to the field of estrogen receptors and particularly though not exclusively on the effect of estrogen receptors and ligands for estrogen receptors on the prevention or treatment of obesity. The invention also relates to the effect of estrogen receptors and their ligands on lipoprotein levels in mammals.

Abstract: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.

Abstract: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.